Introduction {#S1}
============

Gray mold, caused by the ascomycete *Botrytis cinerea* Pers.: Fr. \[teleomorph: *Botryotinia fuckeliana* (de Bary) Whetzel\], is one of the most destructive diseases of crops both pre- and post-harvest ([@B46]; [@B25]). It causes considerable losses in over 200 types of economically valuable vegetables, fruits, and ornamental plants including tomato, cucumber, eggplant, zucchini, strawberry, and grape ([@B46]; [@B40]; [@B30]). Cultivation of plants in greenhouses increases the risk of infection by *B. cinerea* because the presence of high humidity is especially favorable to the pathogen ([@B38]; [@B13]). In China, the percentage of yield loss caused by *B. cinerea* gray mold in vegetable production can be over 60% in some severely infected regions ([@B42], [@B43]).

Control of gray mold is based on integrated management strategies, including cultivar resistance, physical factors, and inoculum reduction. Nevertheless, chemical control remains the main approach for the management of *B. cinerea* diseases ([@B26]; [@B18]; [@B14]; [@B47]). Several site-specific fungicides with different modes of action are available for gray mold management, including methyl benzimidazole carbamates (MBCs), anilinopyrimidines (APs), dicarboximides (DCFs), quinone outside inhibitors (QoIs), succinate dehydrogenase inhibitors (SDHIs), and phenylpyrroles (PPs). Unfortunately, according to the Fungicide Resistance Action Committee (FRAC)^[1](#footnote1){ref-type="fn"}^, *B. cinerea* has been categorized as a high-risk pathogen due to the development of fungicide resistance. Over the last 30 years worldwide, the resistance of *B. cinerea* to these types of fungicides was frequently reported soon after their introduction for gray mold control ([@B35]; [@B36]; [@B49]; [@B16]; [@B8]; [@B47]). Resistance of *B. cinerea* often compromises the efficacy of fungicide and results in disease control failure. The most common disease management practice consists of alternation or tank mixtures of fungicides with different modes of action.

Sterol 14α-demethylase inhibitors (DMIs) are a major group of systemic fungicides that exhibit broad spectra of antifungal activity. The continued and successful use of DMI fungicides, even with the emergence of resistance, justifies the development of new fungicides in this class ([@B7]). The novel fungicide pyrisoxazole (previous Development Code No. SYP-Z048), 3-\[5-(4-chlorophenyl)-2,3-dimethyl- 3-isoxazolidinyl\] pyridine, is developed by the China Shenyang Sinochem Agrochemicals R&D Co., Ltd. (Former: China Shenyang Research Institute of Chemical Industry) ([Supplementary Figure S1](#FS1){ref-type="supplementary-material"}; [@B6]). This fungicide belongs to the pyridine subgroup within the DMI class, like pyrifenox that also has been shown in [Supplementary Figure S1](#FS1){ref-type="supplementary-material"} (FRAC). Pyrisoxazole has shown great promise for the control of a broad range of fungi ([@B29]; [@B42], [@B43]). It has been officially registered for the control of tomato gray mold in China under the tradename Junsiqi in 2008 (China Pesticide Information Network)^[2](#footnote2){ref-type="fn"}^, and is currently being developed for applications on other target pathogens, such as against *Sclerotinia sclerotiorum* in oilseed rape ([@B12]).

Until now, no systematic information has been available on the risk and molecular mechanism(s) of pyrisoxazole resistance in *B. cinerea*. Only one study has reported pyrisoxazole sensitivity in isolates sampled from the Liaoning Province in China ([@B51]). Knowing the resistance basis of fungicides in pathogens is vital for disease management. The basis of resistance of DMI fungicides is most commonly conferred by (i) mutations in the *CYP51* gene, (ii) increased expression of the *CYP51* gene, or (iii) increased expression of membrane-bound transporters ([@B20]; [@B32]; [@B24]; [@B10]; [@B27]). Pyrisoxazole resistance in *Monilinia fructicola* mutants was correlated with the presence of a mutation in the *CYP51* gene that caused an amino acid change from tyrosine to phenylalanine at position 136 ([@B7], [@B6]).

The objectives of this study were to (i) establish a baseline sensitivity of *B. cinerea* isolates from China to the DMI fungicide pyrisoxazole, (ii) generate and characterize pyrisoxazole-resistant mutants to assess the risk of *B. cinerea* developing resistance to pyrisoxazole, and (iii) explore molecular mechanisms that might be responsible for resistance to pyrisoxazole. Such data are essential for subsequent fungicide resistance monitoring programs, as we found two point mutations G476S and M231T in the target protein CYP51 as well as induced expression of the target gene both appeared to contribute to the resistance of *B. cinerea* to pyrisoxazole.

Materials and Methods {#S2}
=====================

Isolates and Culture Conditions {#S2.SS1}
-------------------------------

A total of 110 *B. cinerea* isolates were isolated from diseased tomato leaves or fruits between 2008 and 2012 from nine provinces in northern, central, and southern China where there was no history of pyrisoxazole usage ([Supplementary Table S1](#TS1){ref-type="supplementary-material"}). After purification by single-spore isolation, the isolates were firstly identified as *B. cinerea* and its closely related species by polymerase chain reaction (PCR) using a previously reported primer pair Bc-f/Bc-r designed on the basis of a sequence-characterized amplified region marker ([@B15]). Then, a PCR-restriction fragment length polymorphism (RFLP) analysis of the 18S/28S rRNA intergenic spacer (IGS) region with primers IGS1a and IGS1b was performed to distinguish *B. cinerea* and *B. pseudocinerea*, and the PCR product was digested with HinfI as previously described ([@B23]). All isolates were cultured in darkness on potato dextrose agar (PDA) plates at 20°C. For long-term storage, mycelia of each isolate were maintained in 5 ml plastic tubes containing PDA medium slants under mineral oil at 14°C.

Sensitivity of *B. cinerea* Isolates to Pyrisoxazole {#S2.SS2}
----------------------------------------------------

Pyrisoxazole was standard grade and kindly provided by China Shenyang Sinochem Agrochemicals R&D Co., Ltd. The pyrisoxazole sensitivity of 110 B. cinerea single-spore field isolates was determined by calculating the 50% inhibitory dose (EC~50~ value) on fungicide-amended PDA in Petri plates according to the method previously described in [@B4]. The fungicide concentrations are shown in [Supplementary Table S2](#TS1){ref-type="supplementary-material"}. The final concentration of DMSO solvent in the medium was 0.1%. After incubation for 3 days in darkness at 20°C, each colony diameter (minus 5 mm for the inoculated plug) was measured in two perpendicular directions. Each combination of isolate and fungicide was represented by three replicate plates, and the experiment was performed twice.

Generation of Pyrisoxazole-Resistant Mutants {#S2.SS3}
--------------------------------------------

Ultraviolet (UV) irradiation and spontaneous selection of *B. cinerea* mycelium and conidia on pyrisoxazole-amended media were used in attempts to generate mutants. For the generation of UV irradiation mutants from mycelium, Petri dishes containing 3-day-old actively growing colonies of four DMI-sensitive isolates with different geographical origins and good fitness (S11, H9, T39, NJ10) were exposed for 40-50 min to a 254 nm UV light source placed 10 cm above the cultures. The exposed colonies were incubated in darkness for 1 h, after which mycelial plugs (5 mm in diameter) were excised from the dishes and transferred to PDA plates amended with pyrisoxazole at 1.0 μg/ml (minimal inhibitory concentration). After incubation at 20°C for 7--10 days in darkness, actively growing colonies were transferred to fresh fungicide-free PDA. Five days later, mycelial plugs from the colony periphery were transferred to PDA medium amended with pyrisoxazole at 1.0 μg/ml (the discriminatory concentration) to confirm resistance.

To induce conidia production, mycelial plugs (5 mm) excised from the margin of a 3-day-old PDA colony were placed upside-down on carrot agar medium (CA; 200 g of carrot, 15 g of agar, and distilled water to 1 L). After a 14 h of light and 10 h of darkness for 5-7 days, the conidia were harvested, suspended in 1 ml of sterile water, then treated with UV light (20 W, 254 nm) at 10 cm vertical distance for 45 s at 20°C, followed by 1 h of incubation in darkness to avoid light repair of DNA damage. The conidia were evenly distributed on CA medium amended with pyrisoxazole at 1.0 μg/ml. After 10 days of incubation, developing colonies were transferred to fresh fungicide-free PDA and then transferred to PDA medium amended with pyrisoxazole at 1.0 μg/ml to confirm resistance.

For the generation of spontaneous mutants, the same procedure as above was used but without UV irradiation. The determination of EC~50~ values for putative mutants was conducted as described previously. Each isolate was tested in triplicate and the experiment was repeated once. The mutation frequency as a percentage was calculated as the number of mutants/total number of treated conidia or mycelial plugs × 100; the resistance factor (RF) was calculated according to the formula EC~50~ value of the mutant/ EC~50~ value of its sensitive parent.

Investigation of Control Efficacy Using Detached Leaf Assays {#S2.SS4}
------------------------------------------------------------

Four isolates, including two sensitive parental isolates (S11 and NJ10) and two resistant isolates (RU11-7 and RS10-1), were used to assess fungicide performance on treated leaves, as described previously ([@B50]). Briefly, commercial-variety tomato (cv. BeiBei) leaves of similar size with no fungicide application were rinsed with water for 1 min, and air-dried. The detached leaves were sprayed to run-off with two concentrations (50 or 100 μg/ml) near the label rate of pyrisoxazole (75--150 μg/ml) diluted in Tween-80 water, respectively. Control leaves were sprayed with sterile distilled Tween-80 water. Leaves were allowed to dry overnight at 20°C. Mycelial plugs (5 mm in diameter) taken from the margins of the actively growing colony were placed upside down on the leaves. After inoculation, the plastic boxes were sealed with plastic bags to keep the relative humidity near 100%. After 5 days at 20°C with 12 h of light and 12 h of darkness, the lesion area on each leaf was measured. The experiment was conducted twice independently. Control efficacy was calculated according to the following formula: Control efficacy = (\[lesion area with water application -- lesion area with fungicide treatment\] / lesion area with water application) × 100%.

Stability of Pyrisoxazole Resistance in Mutants {#S2.SS5}
-----------------------------------------------

Mycelial plugs taken from the periphery of actively growing colonies were transferred a total of 10 times to fresh, fungicide-free PDA medium. EC~50~ values for pyrisoxazole were determined before the transfer and after the 5th and 10th transfer. Each mutant was evaluated in triplicate, and the entire experiment was conducted twice.

Mycelial Growth Rate Over a Series of Temperatures {#S2.SS6}
--------------------------------------------------

Mycelial plugs (5 mm in diameter) of each isolate were transferred from the leading edge of an actively growing colony to PDA dishes and incubated in darkness at 4, 20, 25, 28, or 39°C. Colony diameter was measured after 2 days of incubation. Each combination of isolate or mutant and temperature was represented by three replicate plates, and the experiment was conducted twice.

Conidia Production and Germination Rate *in vitro* {#S2.SS7}
--------------------------------------------------

Conidia were induced as described in the previous section and harvested by rinsing the sporulating colony in each plate with 10 ml of a 0.1% aqueous glucose solution. The number of conidia in the suspension were counted with a hemacytometer and a microscope. To determine the rate of germination, the conidial suspension was adjusted to 10^5^-10^6^ conidia/ml and 50 μl of the suspension was spread onto depression slides placed on top of wet filter paper in a petri dish. The depression slides were incubated at 20°C for 6 h in darkness. In total, 200 conidia were assessed per isolate for germination ability under a microscope. Each isolate was tested in triplicate and the entire experiment was repeated once.

Pathogenicity, Conidial Production, and Germination Rate *in vivo* {#S2.SS8}
------------------------------------------------------------------

Pathogenicity of *B. cinerea* was determined on detached leaves of "BeiBei" as described above, but without fungicide treatment. Controls consisted of leaves that were punctured and then inoculated with a sterile agar plug or distilled water. After 5 days at 20°C with 12 h of light and 12 h of darkness, the lesion area on each leaf was measured. The experiments were performed twice.

Conidia production *in vivo* was measured by inoculating leaves as described in the previous paragraph. After incubation at 20°C for another 7--10 days, the number of conidia and the germination rate were determined in a 0.1% aqueous glucose solution. Each isolate was tested in triplicate and the *in vivo* sporulation experiments were performed twice.

Sclerotia Production {#S2.SS9}
--------------------

For comparison of sclerotia production, an agar plug cut from the edge of a 3-day-old colony on PDA was placed in the center of a 9 cm diameter Petri dish. After 20 days at 20°C in darkness, sclerotia were removed from the cultures and dried to a constant weight at 50°C for 16 h. Sclerotia production was expressed as sclerotia dry mass per Petri dish. Each isolate or mutant was represented by three replicate Petri dishes, and the experiment was conducted twice.

Competitive Ability {#S2.SS10}
-------------------

Competitive ability was determined for five combinations of the sensitive parental isolates (S) and their resistant mutants (R): S11 versus RU11-7, S11 versus RU11-21, NJ10 versus RS10-1, NJ10 versus RS10-4, and NJ10 versus RS10-5. Each combination consisted of three ratios of the S and R isolates (9R:1S, 5R:5S, and 1R:9S), which were prepared by mixing conidial suspensions of the pyrisoxazole sensitive isolates and the corresponding resistant mutants. Conidial suspensions were prepared as described earlier, and the final concentration for each was adjusted to 1 × 10^5^/ml with the aid of a hemacytometer and microscope. A 100 μl volume of each of the resulting conidial suspensions was spread on a CA plate, and the cultures were grown, and conidia were harvested as described earlier. This procedure was repeated five times (five subcultures). After the 1st, 3rd, and 5th subculture, 70 single conidial isolates were obtained and transferred to PDA plates amended with 1 μg/ml pyrisoxazole. Isolates that were able to grow on the plates amended with the discriminatory concentration of pyrisoxazole were considered resistant, and those that could not were considered sensitive. The ratios of the resistant and sensitive isolates obtained after subculture on CA were calculated and compared with the original ratios. This experiment was performed twice.

Cross-Resistance {#S2.SS11}
----------------

The pyrisoxazole-resistant mutants and their parents were exposed to two DMIs (tebuconazole, and prochloraz) belonging to different chemical groups, and five other fungicides of different modes of action (iprodione, procymidone, diethofencarb, fluazinam, pyrimethanil, and fludioxonil). The EC~50~ values for each isolate/fungicide combination were determined using the aforementioned mycelial growth inhibition method, except that glucose-gelatin-agar medium (0.4% glucose, 0.4% gelatin, 0.177% K~2~HPO~4~, 0.036% MgSO~4~⋅7H~2~O, and 1.2% agar) was used for pyrimethanil ([@B3]), and salicylhydroxamic acid was added to the azoxystrobin-amended medium with a final concentration of 100 μg/ml to inhibit the alternative respiration pathway ([@B2]). The concentrations used for each fungicide are provided in [Supplementary Table S2](#TS1){ref-type="supplementary-material"}. Each treatment had three replicate plates, and the experiment was conducted twice.

Cloning and Sequencing of the *BcCYP51* Gene {#S2.SS12}
--------------------------------------------

Genomic DNA was extracted from mycelium, as described previously ([@B9]). The complete *BcCYP51* gene was amplified with primer pair BcCYP51-F and BcCYP51-R as described previously ([@B1]). The amplified *BcCYP51* full-length fragments were purified using the EasyPure Quick Gel Extraction Kit (TransGen, Beijing, China) and were cloned into the pEASY-T1 simple plasmid (TransGen, Beijing, China) according to the manufacturer's recommendations. The vector inserted into *Escherichia coli* was sequenced (Sunbiotech Co., Beijing) using vector primers M13F (5′-ACTGGCCGTCGTTTTAC-3′) and M13R (5′-GTCCTTTGTCGATACTG-3′). DNA sequences were analyzed with DNAMAN software (Lynnon BioSoft, Quebec, Canada).

Determination of the Expression Level of *CYP51* {#S2.SS13}
------------------------------------------------

Each isolate was grown in 150 ml Erlenmeyer flasks containing 80 ml of PDB liquid medium. After 3 days at 20°C on a rotary shaker at 150 rpm, pyrisoxazole (EC~50~ value for each isolate) was added to three of the six flasks for each isolate. After 24 h, mycelia were harvested by vacuum filtration for RNA extraction. Total RNA was extracted by the SV Total RNA Isolation Kit (Promega, Beijing, China), and cDNA was synthesized using the PrimeScript RT Reagent Kit with gDNA Eraser (Takara, Beijing, China), following the manufacturer's instructions.

The expression level of the target genes was quantified by quantitative real-time PCR (qRT-PCR), which was performed with an ABI7500 sequence detection system (Applied Biosystems, United States). qRT-PCR was conducted in a 20 μl reaction volume with the SYBR Premix Dimer Eraser Kit (Takara, Beijing, China). The following program were used for the qRT-PCR analysis by three biological replications: 95°C for 30 s, followed by 40 cycles of 95°C for 5 s, 60°C for 30 s, and 72°C for 34 s. Primers used for qRT-PCR were CYP51-QF/QR (5′-ATTTGGTGCTGGCAGACATAGA-3′; 5′-GTGAATAAACTTGCGTAATCG GTA-3′) for the *BcCYP51* gene and Actin-QF/QR (5′-CTGGTCGTGATTT GACTGATTA-3′; 5′-GATTGACTGGCGGT TTGG-3′) for the reference gene *actin*. The relative quantities (RQs) of products were calculated using the 2^--ΔΔCt^ method ([@B31]). Three independent experiments were conducted.

Molecular Docking Analysis {#S2.SS14}
--------------------------

Bioinformatic analysis was used to investigate the molecular docking of pyrisoxazole with the BcCYP51 protein. The crystal structure of 5HS1, a CYP51 protein from the yeast *Saccharomyces cerevisiae* bound with voriconazole, was retrieved from the Protein Data Bank and used in the current study. Sequence alignment by DNAMAN software indicated that the CYP51 amino acid residues of *S. cerevisiae* showed about 45% sequence identity with that of *B. cinerea*. The crystal structure 5HS1 was a suitable template for studying the binding conformation of pyrisoxazole with the BcCYP51 protein.

The modeling structure of *B. cinerea* was obtained by using the template 5HS1 and the online Swiss-model software^[3](#footnote3){ref-type="fn"}^. The binding cavity was predicted by a ligand mode for voriconazole complexed in CYP51 by the SYBYL 7.3 software program. The Biopolymer-Replace Sequence subset from the Sybyl X2.0 software package was used to produce site-directed mutations at residues K104, G476, and M231, respectively. The Tripos force field with Gasteiger--Marsili charges was used for energy minimization. The molecular conformations of pyrisoxazole were constructed by Sketch mode and were optimized using the Tripos force field and Gasteiger--Hückel charge. The Surflex-Dock of SYBYL 7.3 was used for the molecular docking modeling ([@B22]). The binding cavity was set as "ligand," and the total score was used to evaluate the binding affinity between ligand and protein ([@B21]). All molecular modeling between the putative *B. cinerea* CYP51 proteins with ligand was conducted on the Silicon Graphics (SGI) Fuel Workstation (Silicon Graphics International Corp., CA, United States).

Statistical Analysis {#S2.SS15}
--------------------

Data were analyzed by SPSS software (ver. 21.0) based on an unpaired Student's *t-*test. An asterisk indicates significant differences with the *P-*values marked (^∗^*P* \< 0.05; ^∗∗^*P* \< 0.01, ^∗∗∗^*P* \< 0.001). Cross-resistance between two fungicides was analyzed using Spearman's rank correlation coefficient with log-transformed EC~50~ values.

Results {#S3}
=======

Baseline Sensitivity of *B. cinerea* in China to Pyrisoxazole {#S3.SS1}
-------------------------------------------------------------

The EC~50~ values required for pyrisoxazole to inhibit mycelial growth of *B. cinerea* field isolates collected from nine provinces in China ranged from 0.020 to 0.166 μg/ml, with a mean EC~50~ of 0.057 ± 0.029 μg/ml ([Figure 1](#F1){ref-type="fig"}). The ratio of the maximum EC~50~ to the minimum EC~50~ was 8.3. The range and mean of EC~50~ values in different populations are listed in [Supplementary Table S1](#TS1){ref-type="supplementary-material"}. The narrow range and low EC~50~ values of the *B. cinerea* isolates indicate no preexisting pyrisoxazole resistance.

![Frequency distribution of effective concentrations for 50% growth inhibition (EC~50~) of pyrisoxazole against 110 *Botrytis cinerea* isolates.](fmicb-11-01396-g001){#F1}

Generation of Pyrisoxazole-Resistant Mutants {#S3.SS2}
--------------------------------------------

No mutants were obtained from UV irradiation and spontaneous selection of mycelium. Six resistant mutants, designated as RU11-1, RU11-5, RU11-7, RU11-12, RU11-15, and RU11-21, were obtained from conidia of parental wild-type isolate S11 treated with UV light. Five mutants, designated as RS10-1 to RS10-5, were obtained from spontaneous selection from the conidia of parental isolate NJ10. EC~50~ values of the mutants from UV irradiation ranged from 0.293 to 0.565 μg/ml, with corresponding resistance factors of 4.7--9.1 ([Table 1](#T1){ref-type="table"}). The mutation frequency from UV irradiation of conidia was 6.5 × 10^--9^. EC~50~ values of the mutants from spontaneous selection of conidia ranged from 0.337 to 0.453 μg/ml with corresponding resistance factors of 7.6--10.1 ([Table 1](#T1){ref-type="table"}). The average mutation frequency from spontaneous selection of conidia was 5.0 × 10^--9^.

###### 

Stability and level of pyrisoxazole resistance of two groups of *Botrytis cinerea* mutants and their parental isolates, S11 and NJ10, after the 1st, 5th, and 10th subculture on fungicide-free medium.

  Isolate^a^   EC~50~ (μg/ml)   RF^b^   FSC^c^                      
  ------------ ---------------- ------- -------- ------ ----- ----- -----
  S11          0.062            0.055   0.057    --     --    --    --
  RU11-3       0.545            0.375   0.465    8.8    6.8   8.2   0.9
  RU11-5       0.310            0.268   0.350    5.0    4.9   6.1   1.2
  RU11-7       0.293            0.229   0.342    4.7    4.2   6.0   1.3
  RU11-12      0.326            0.313   0.353    5.3    5.7   6.2   1.2
  RU11-15      0.438            0.313   0.374    7.1    5.7   6.6   0.9
  RU11-21      0.565            0.455   0.417    9.1    8.3   7.3   0.8
                                                                    
  NJ10         0.045            0.049   0.046    --     --    --    --
  RS10-1       0.337            0.316   0.355    7.6    6.4   7.7   1.0
  RS10-2       0.401            0.379   0.331    8.9    7.7   7.2   0.8
  RS10-3       0.385            0.418   0.417    8.6    8.5   9.1   1.1
  RS10-4       0.358            0.327   0.327    8.0    6.7   7.1   0.9
  RS10-5       0.453            0.440   0.433    10.1   9.0   9.4   0.9

a

S11 and NJ10 correspond to the wild-type parental isolates.

b

RF = resistance factor, the radio of the EC

50

of the fungicide-resistant mutant to that of its wild-type parent.

c

FSC = factor of sensitivity change, the radio of RF values for EC

50

at the 10th to the 1st transfer.

Detached Leaf Assays {#S3.SS3}
--------------------

All isolates were able to infect and develop lesions on tomato leaves without fungicide treatment. Lesion development of DMI-sensitive isolates (S11 and NJ10) or resistant isolates (RU11-7 and RS10-1) was decreased on leaves sprayed with pyrisoxazole, compared with the control treatment. However, the control efficacy for two resistant isolates with the lowest resistance factors was about 20% lower than that for the sensitive isolates at the two tested fungicide concentrations ([Figure 2](#F2){ref-type="fig"}). The results demonstrated that there was a significant difference (*P* \< 0.05) in control efficacy between sensitive and resistant isolates, indicating that reduced sensitivity of *B. cinerea* isolates to pyrisoxazole did occur.

![Control efficacy of gray mold of pyrisoxazole-treated tomato leaf inoculated with pyrisoxazole-sensitive (S11, NJ10) and resistant (RU11-7, RS10-1) isolates. Columns and bars indicate means ± standard deviation (SD) from replicates. An asterisk indicates significant differences based on an unpaired Student's *t-*test with the *P-*values marked (\**P* \< 0.05; \*\**P* \< 0.01, \*\*\**P* \< 0.001).](fmicb-11-01396-g002){#F2}

Resistance Level and Stability {#S3.SS4}
------------------------------

To determine the fitness of pyrisoxazole-resistant mutants, the level of pyrisoxazole resistance of the mutants was measured, and the RF values (resistance factor, the ratio of the EC~50~ value of a resistant mutant to that of its parent) was determined. After 10 transfers on fungicide-free PDA, the FSC values (factor of sensitivity change, the ratio of RF values at the 10th to the 1st transfer) ranged from 0.8 to 1.3, indicating that resistance was stable.

Colony Growth as Affected by Temperature {#S3.SS5}
----------------------------------------

For all of the pyrisoxazole-resistant mutants and their parental isolate of *B. cinerea*, the optimal temperature for mycelial growth was 20°C ([Table 2](#T2){ref-type="table"}). Most mutants grew at the same rate as their parental isolates at all the tested temperatures, except RU11-3 and RU11-21: these grew slower than their parental isolate S11 at 20, 25, and 28°C ([Table 2](#T2){ref-type="table"}). All isolates of *B. cinerea* did not grow at 39°C.

###### 

Effect of temperature on the mycelial growth of resistant mutants of *Botrytis cinerea* and their wild-type parents on PDA without fungicide.

  Isolate^a^   Colony diameter (mm)^b^                                                   
  ------------ ------------------------- --------------- --------------- --------------- ----
  S11          0.6 ± 0.1                 4.1 ± 0.1       3.8 ± 0.2       2.1 ± 0.1       --
  RU11-3       0.6 ± 0.1                 3.7 ± 0.2\*     3.1 ± 0.2\*\*   1.6 ± 0.1\*\*   --
  RU11-5       0.4 ± 0.0                 4.2 ± 0.1       3.7 ± 0.2       1.8 ± 0.1       --
  RU11-7       0.4 ± 0.1                 4.0 ± 0.1       3.1 ± 0.1\*     1.8 ± 0.2       --
  RU11-12      0.5 ± 0.0                 4.2 ± 0.1       3.8 ± 0.2       1.9 ± 0.2       --
  RU11-15      0.4 ± 0.1                 4.0 ± 0.1       4.0 ± 0.2       1.8 ± 0.1       --
  RU11-21      0.3 ± 0.0\*               3.5 ± 0.2\*\*   3.1 ± 0.2\*\*   1.5 ± 0.1\*\*   --
                                                                                         
  NJ10         0.6 ± 0.0                 4.2 ± 0.1       3.6 ± 0.2       2.2 ± 0.1       --
  RS10-1       0.4 ± 0.1                 4.2 ± 0.2       3.5 ± 0.2       1.9 ± 0.1       --
  RS10-2       0.4 ± 0.0                 4.2 ± 0.1       3.7 ± 0.2       1.9 ± 0.1       --
  RS10-3       0.5 ± 0.1                 4.0 ± 0.1       3.4 ± 0.3       1.8 ± 0.2       --
  RS10-4       0.4 ± 0.0                 4.1 ± 0.1       3.7 ± 0.2       1.9 ± 0.2       --
  RS10-5       0.4 ± 0.1                 4.0 ± 0.2       3.7 ± 0.3       1.8 ± 0.1       --

a

Colony diameter was measured after incubation for three days at 20°C. S11 and NJ10 correspond to the wild-type parental isolates.

b

Values in a column indicate means ± SD. An asterisk indicates significant differences based on an unpaired Student's t-test with the P-values marked (

∗

P \< 0.05;

∗∗

P \< 0.01,

∗∗∗

P \< 0.001).

c

"--"means the isolates could not grow at 39°C.

Most Resistant Mutants Experienced Fitness Penalty {#S3.SS6}
--------------------------------------------------

The average mycelial growth rate did not significantly differ for most pyrisoxazole-resistant mutants compared to the parental wild-type isolate, except for RU11-3 and RU11-21 ([Table 3](#T3){ref-type="table"}). Spore production was significantly lower for the mutants than for their parents except for RU11-21 and RS10-1, regardless of whether produced *in vitro* or *in vivo* ([Table 3](#T3){ref-type="table"}). All the RU-mutants had a reduced conidia germination rate, and the RS-mutants exhibited similar germination rates to that of the wild-type isolate in *vivo* ([Table 3](#T3){ref-type="table"}). Sclerotium production was significantly reduced in the RU-mutants but was higher in the RS-mutants except for RS10-1 ([Table 3](#T3){ref-type="table"}). The lesion area produced on detached tomato leaf was significantly reduced in the mutants compared to the parental wild-type isolate ([Table 3](#T3){ref-type="table"}).

###### 

Comparison of fitness parameters for resistant *Botrytis cinerea* mutants and their wild-type parental isolate^a^.

                            *In vitro*        *In vivo*                                                                     
  --------- --------------- ----------------- ------------------ ----------------- ------------------ --------------------- -----------------
  S11       2.1 ± 0.1       5.3 ± 0.7         85.4 ± 2.1         9.7 ± 1.1         96.3 ± 1.7         0.045 ± 0.006         2.9 ± 0.3
  RU11-3    1.8 ± 0.2\*     1.2 ± 0.1\*\*\*   38.7 ± 3.4\*\*\*   7.3 ± 0.3\*\*\*   48.4 ± 2.1\*\*\*   0.135 ± 0.012\*\*\*   1.7 ± 0.3\*\*\*
  RU11-5    2.1 ± 0.1       0.7 ± 0.1\*\*\*   0.7 ± 0.3\*\*\*    5.5 ± 0.3\*\*\*   61.0 ± 1.7\*\*\*   0.176 ± 0.003\*\*\*   2.2 ± 0.2\*\*\*
  RU11-7    2.0 ± 0.1       0.8 ± 0.4\*\*\*   3.3 ± 0.6\*\*\*    0.4 ± 0.1\*\*\*   8.2 ± 2.4\*\*\*    0.140 ± 0.006\*\*\*   1.9 ± 0.2\*\*\*
  RU11-12   2.1 ± 0.1       0.8 ± 0.2\*\*\*   20.5 ± 2.4\*\*\*   4.9 ± 0.7\*\*\*   33.3 ± 1.0\*\*\*   0.173 ± 0.008\*\*\*   2.2 ± 0.2\*\*\*
  RU11-15   2.0 ± 0.1       1.5 ± 0.2\*\*\*   57.1 ± 1.6\*\*\*   8.7 ± 0.3\*\*     57.2 ± 2.6\*\*\*   0.155 ± 0.024\*\*\*   2.0 ± 0.2\*\*\*
  RU11-21   1.8 ± 0.2\*\*   5.2 ± 0.8         34.3 ± 3.2\*\*\*   9.2 ± 0.3         23.8 ± 3.3\*\*\*   0.078 ± 0.007\*\*     1.6 ± 0.1\*\*\*
                                                                                                                            
  NJ10      2.1 ± 0.1       5.2 ± 0.7         54.2 ± 5.9         8.6 ± 0.9         90.6 ± 3.0         0.257 ± 0.032         2.2 ± 0.4
  RS10-1    2.1 ± 0.2       5.2 ± 0.2         78.3 ± 4.1\*\*     8.3 ± 0.3         92.4 ± 2.1         0.213 ± 0.029         0.3 ± 0.1\*\*\*
  RS10-2    2.1 ± 0.1       1.2 ± 0.4\*\*\*   60.6 ± 1.2         2.5 ± 0.6\*\*\*   88.5 ± 1.7         0.201 ± 0.022\*       0.7 ± 0.3\*\*\*
  RS10-3    2.0 ± 0.1       2.3 ± 0.7\*\*\*   45.8 ± 9.3         0.9 ± 1.0\*\*\*   90.2 ± 2.4         0.196 ± 0.019\*       1.1 ± 0.2\*\*\*
  RS10-4    2.1 ± 0.1       2.0 ± 0.2\*\*\*   70.1 ± 3.7\*\*     3.6 ± 0.9\*\*\*   93.4 ± 1.8         0.002 ± 0.001\*\*\*   1.4 ± 0.2\*\*\*
  RS10-5    2.0 ± 0.2       0.9 ± 0.2\*\*\*   72.0 ± 6.0\*\*     2.7 ± 1.3\*\*\*   87.2 ± 5.6         0.113 ± 0.021\*\*\*   1.6 ± 0.3\*\*\*

a

Values in a column indicate means ± standard deviation (SD). An asterisk indicates significant differences based on an unpaired Student's t-test with the P-values marked (

∗

P \< 0.05;

∗∗

P \< 0.01,

∗∗∗

P \< 0.001).

b

S11 and NJ10 correspond to the wild-type parental isolates.

c

Growth rate was determined at the optimum temperature of 20°C.

Competitive Ability {#S3.SS7}
-------------------

The observed frequency of pyrisoxazole-resistant isolates was less than the expected frequency in the combinations S11 versus RU11-7, S11 versus RU11-21, and NJ10 versus RS10-4 regardless of whether it was after the 1st, 3rd, or the 5th transfers ([Figures 3A,B,D](#F3){ref-type="fig"}). For the NJ10 versus RS10-5 combination, the drop in the observed frequency of pyrisoxazole-resistant isolates occurred after the 3rd transfer ([Figure 3E](#F3){ref-type="fig"}). However, RS10-1 showed a higher competitive ability than its parent NJ10 as indicated in [Figure 3C](#F3){ref-type="fig"}. The results indicated that most of the pyrisoxazole-resistant isolates were less fit than the sensitive wild-type isolates, except RS10-1.

![Competition between pyrisoxazole-sensitive and resistant isolates of *Botrytis cinerea* as indicated by the resistance ratios after 1st, 3rd, and 5th subcultures on agar medium. Five combinations of the sensitive parental isolates (S) and their resistant mutants (R) were determined: **(A--E)** representing S11 versus RU11-7, S11 versus RU11-21, NJ10 versus RS10-1, NJ10 versus RS10-4, and NJ10 versus RS10-5, respectively. Each combination consisted of three ratios of the S and R isolates (9R:1S, 5R:5S, and 1R:9S), which were prepared by mixing conidia suspensions of the pyrisoxazole-sensitive isolates and the corresponding resistant mutants.](fmicb-11-01396-g003){#F3}

Cross-Resistance {#S3.SS8}
----------------

For the 11 pyrisoxazole-resistant mutants and 11 sensitive field isolates tested, there was no correlation between sensitivity to pyrisoxazole and that to iprodione, procymidone, diethofencarb, fluazinam, pyrimethanil, or fludioxonil ([Figures 4A--F](#F4){ref-type="fig"}). A positive correlation was observed between sensitivity to pyrisoxazole and that to DMIs tebuconazole (ρ = 0.82, *P* \< 0.0001) and prochloraz (ρ = 0.70, *P* = 0.0002) ([Figures 4G,H](#F4){ref-type="fig"}).

![Cross-resistance between pyrisoxazole and **(A)** iprodione, **(B)** procymidone, **(C)** diethofencarb, **(D)** fluazinam, **(E)** pyrimethanil, **(F)** fludioxonil, **(G)** tebuconazole, or **(H)** prochloraz by rank correlation analysis. Data shown in logarithmic values of effective concentrations for 50% mycelial growth inhibition (log EC~50~) among *Botrytis cinerea* for fungicide combinations.](fmicb-11-01396-g004){#F4}

Molecular Analysis of the CYP51 Gene in *B. cinerea* {#S3.SS9}
----------------------------------------------------

The *CYP51* genes of the pyrisoxazole-resistant mutants and their parental isolates were cloned and sequenced (GenBank accession numbers: [MT430873](MT430873) for the sensitive isolate S11, MT430874 for the RU-mutant, MT430875 for the sensitive isolate NJ10, and MT430876 for the RS-mutant). An annotated alignment of CYP51 protein for several fungal species was shown in [Figure 5A](#F5){ref-type="fig"}, and the ZtCYP51 sequence from *Zymoseptoria tritici* (accession number [AY253234](AY253234)) was used as the archetype protein to unify the labeling of amino acids in fungicide target proteins ([Figure 5A](#F5){ref-type="fig"}; [@B33]). Multiple sequence alignment revealed a two-point mutation, at amino acid positions 104 and 476 in all RU-mutants ([Figure 5B](#F5){ref-type="fig"}), and a point mutation at amino acid position 231 in RS-mutants ([Figure 5C](#F5){ref-type="fig"}). For the resistant mutants acquired from UV irradiation, lysine was substituted for glutamic acid at codon 104 (K104E), and glycine was substituted for serine at codon 476 (G476S). Methionine was substituted for threonine at codon 231 (M231T) for the mutants acquired from spontaneous selection ([Figures 5B,C](#F5){ref-type="fig"}). The expression level of *CYP51* gene was further determined, with and without pyrisoxazole treatment. It is found that the expression level of *CYP51* was significantly induced by pyrisoxazole in the resistant mutants. It increased by 1.5--2.4-fold in RU-mutants compared to its parental wild-type isolate S11; and 2.2--3.2-fold in RS-mutants compared to NJ10 ([Figure 6](#F6){ref-type="fig"}).

![Multiple sequence alignment of the CYP51 proteins in *Botrytis cinerea* sensitive parental isolates with that in **(A)** six other fungal species; **(B)** six resistant mutants (RU-mutants) generated from UV irradiation of conidia; **(C)** five resistant mutants (RS-mutants) acquired from the spontaneous selection of conidia. S11 and NJ10 correspond to the wild-type parental isolates.](fmicb-11-01396-g005){#F5}

![Constitutive and fungicide-induced expression of *CYP51* from pyrisoxazole resistant *Botrytis cinerea* mutants and the corresponding sensitive parental isolates S11 and NJ10. Relative expression of *CYP51* was calculated by the 2^--ΔΔCt^ method with the *actin* gene as reference. Expression in each isolate was relative to the expression of isolate S11. Columns and bars indicate mean ± SD for replicates. An asterisk indicates significant differences between each pyrisoxazole-resistant isolate and its parental sensitive isolate based on an unpaired Student's *t-*test with the *P-*values marked (\**P* \< 0.05; \*\**P* \< 0.01).](fmicb-11-01396-g006){#F6}

Analysis of the Affinity Between the Mutation Positions and Pyrisoxazole {#S3.SS10}
------------------------------------------------------------------------

Models were built for pyrisoxazole docking into the CYP51 binding pocket with the following mutations: K104E, G476S, and M231T. The docking scores of these predicted models are shown in [Figure 7A](#F7){ref-type="fig"}. The model for the wild-type indicated that there were seven electrostatic interactions between CYP51 and pyrisoxazole ([Figure 7B](#F7){ref-type="fig"}). The amino acid mutation G476S caused the migration of pyrisoxazole binding sites in the CYP51 and thereby led to the loss of four electrostatic interactions ([Figure 7C](#F7){ref-type="fig"}). The docking score decreased from approximately 6.19--5.33 for this G476S mutation ([Figure 7A](#F7){ref-type="fig"}). Two electrostatic interactions disappeared with the M231T mutation ([Figure 7D](#F7){ref-type="fig"}). As a result, the docking score changed from 6.19 for M231 and to 5.72 for T231 ([Figure 7A](#F7){ref-type="fig"}). No change was found with the K104E mutation, which is also reflected by the unchanged score ([Figure 7E](#F7){ref-type="fig"}).

![Docking of pyrisoxazole in the modeled binding pockets of CYP51 in *Botrytis cinerea*. The structure of *B. cinerea* was modeled using the template of 5HS1 from *Saccharomyces cerevisiae* by the online Swiss-model software. **(A)** Total scores of pyrisoxazole docked into the CYP51 binding site of *B. cinerea* wild-type and mutated models; **(B--E)** represent the binding pockets of pyrisoxazole in the wild-type CYP51 **(B)**, or with mutation G476S **(C)**, M231T **(D)**, or K104E **(E)** of *B. cinerea.*](fmicb-11-01396-g007){#F7}

Discussion {#S4}
==========

In this study, we established the baseline sensitivity of *B. cinerea* to pyrisoxazole using isolates from nine provinces in China, which represents the first step in monitoring and managing the development of fungicide resistance in the field ([@B39]). Given that the isolates were collected before pyrisoxazole was widely applied to fields in China, the EC~50~ values obtained provide a very accurate measure of the baseline sensitivity of *B. cinerea* to pyrisoxazole in this context. [@B51] determined the sensitivity of *B. cinerea* to pyrisoxazole from Liaoning province. As the isolates used in the present study were collected from the northern, central, and southern regions of China, the results can be used to provide a baseline for monitoring changes in the sensitivity of *B. cinerea* populations to pyrisoxazole in China. The low EC~50~ values (mean: 0.057 μg/ml) in this study were consistent with the previous report with the mean EC~50~ of 0.068 μg/ml ([@B51]), and these provide strong evidence of no pyrisoxazole-resistant subpopulations existing in wild populations of *B. cinerea*. Moreover, the intrinsic activity of pyrisoxazole on *B. cinerea* was higher than most DMI fungicides, such as teuconazole used in the current study, as well as previous reported propiconazole and triflumizole ([@B34]; [@B45]). In detail, the activity is about 5 or 10 times greater compared to teuconazole, or triflumizole, respectively. In addition, it showed a similar intrinsic activity with pyrifenox to *B. cinerea* ([@B19]). It is speculated that there may be some difference in the binding of DMIs in CYP51 protein of *B. cinerea*.

No mutants were obtained from mycelium of *B. cinerea*. The mutation frequency from UV irradiation and spontaneous selection of conidia was 6.5 × 10^--9^, and 5.0 × 10^--9^, respectively. This low mutation frequency is in contrast to a previous study reporting frequent development of *Z. tritici* mutants resistant to DMI fungicides via spontaneous selection at a relatively high rate of about 10^--4^ ([@B52]). Consistent with *B. cinerea*, no pyrisoxazole-resistant mutants were obtained by spontaneous selection in the study of *M. fructicola*, and the average mutation frequency from the conidia of *M. fructicola* exposed to UV irradiation under pyrisoxazole treatment was 8.3 × 10^--10^ ([@B6]). The very low frequency at which *B. cinerea* and *M. fructicola* generate pyrisoxazole-resistant mutants is mirrored by the fact that mutants have not been observed in fields sprayed with DMI fungicides multiple times or over several years. However, the average mutation frequency under pyrisoxazole treatment from the mycelium of *M. fructicola* was much higher, indicating that there is still the possibility to obtain mutants from *B. cinerea* mycelium. In the future work, more fungicide concentrations could be used for the screening of pyrisoxazole-resistant mutants.

On fungicide-treated tomato leaves, presumably the mutants with the lowest RF values are more difficult to control compared with sensitive isolates ([Figure 2](#F2){ref-type="fig"}), indicating that reduced sensitivity of *B. cinerea* isolates to pyrisoxazole did occur. A comparison of the biological characteristics with the parental isolate indicated that there was a significant fitness penalty for most mutants, suggesting the spread of resistant mutants may be affected in the field. This was confirmed by the competitive ability test in which most of the resistant mutants showed a substantial drop in the observed frequency of pyrisoxazole-resistant isolates ([Figure 3](#F3){ref-type="fig"}). However, some mutants bearing the same mutation in the target protein, such as RS10-1, showed an unimpaired fitness and even a higher competitive ability than its parent NJ10. It could be explained that some mutations might alter other areas of the genome as fitness penalty is not necessarily due to the mutations in the target CYP51 protein. Given the mutation frequency and cross-resistance results, the resistance risk of *B. cinerea* to pyrisoxazole may be considered to be low. Considering that the mutant RS10-1 still showed a good fitness and the control efficacy was clearly reduced when inoculating plants with these resistant mutants, it indicated that if such a mutation arises in field populations of *B. cinerea*, they could also possibly survive in the field. Therefore, on one hand, it is advisable to closely monitor any sensitivity changes to pyrisoxazole in *B. cinerea* populations in the field; on the other hand, more mutants with other phenotype and fitness should be obtained to further optimize this conclusion of resistance risk.

We found strong positive cross-resistance between pyrisoxazole and two DMIs in the mutants with different chemistries, and previous study also revealed cross-resistance between pyrisoxazole and propiconazole in *M. fructicola* mutants ([@B6]). Cross-resistance was not found between DMI and non-DMI fungicides in the current study. This is consistent with the cross-resistance reports on *M. fructicola* and *S. sclerotiorum* ([@B6]; [@B12]). The efficacy of different commonly used fungicides has been decreased by the development of resistant *B. cinerea* isolates (as mentioned in "Introduction" section). Therefore, pyrisoxazole can be used in rotation for better management of gray mold. Mixtures of pyrisoxazole and the protective fungicide chlorothalonil or thiram have been reported to be highly effective for the control of *B. cinerea* ([@B41]). This can lower the selection pressure to slow down DMI resistance development.

Point mutations in the CYP51 protein and over-expression of the *CYP51* gene are two main determinants of DMI resistance. The third hypothesis is resulted from over-expression of transporter genes, which is usually indicated by different spectrum of cross-resistance in resistant mutants depend upon the transporter involved ([@B20]; [@B32]). No cross-resistance was found between DMIs and six non-DMIs in the mutants, it indicated that increased expression of membrane-bound transporters was not the main reason for the fungicide resistance and more kinds of fungicides could be used to explain this issue in the future. In this study, we firstly cloned and characterized the target gene *CYP51* for *B. cinerea* and three point mutations K104E, G476S, M231T, were found in resistant *B. cinerea* mutants. Previous studies demonstrated that point mutation G461S in the MfCYP51 protein (corresponds to G476S in the reference ZtCYP51 sequence) is associated with tebuconazole resistance in *M. fructicola* populations in Brazil ([@B28]). [@B17] listed the same mutation in *Podosphaera xanthii* resistant to DMI fungicides. Similar mutation was also reported in *Pyrenopeziza brassicae* with reduced tebuconazole sensitivity ([@B5]). This indicates these point mutations, especially the G476S mutation detected in the current study, might play roles in the resistance to pyrisoxazole of *B. cinerea*. Then, we found that the induced expression level of *CYP51* increased in the resistant isolates when exposed to pyrisoxazole ([Figure 6](#F6){ref-type="fig"}). Therefore, it indicated that point mutations in the CYP51 protein and the increased expression of the *CYP51* gene both appeared to mediate the pyrisoxazole resistance of *B cinerea*.

The point mutations could change the conformation of the binding pocket in 14α-demethylase and reduce its potential to bind DMI fungicides ([@B44]; [@B48]; [@B37]). Molecular docking was used to explore the conformation change in the binding pocket of CYP51 of *B cinerea*, with or without point mutations. As expected, mutation G476S in CYP51 changed the conformation of pyrisoxazole in the binding pocket, and G476S and M231T mutations both led to the loss of electrostatic interactions, indicating these two mutations contributed to pyrisoxazole resistance the *B cinerea*. In addition, the score of molecular docking decreased less than in the RS-mutants with M231T mutation, which may be related to the higher induced expression level of *CYP51* in such mutants. According to our knowledge, this is the first report of M231T mutation on CYP51 protein in the DMI-resistant mutants, which needs further verification in the following work. Mutation K104E did not affect the binding of BcCYP51 and pyrisoxazole, and this amino acid position was also not conversed in different fungal species as shown in [Figure 6A](#F6){ref-type="fig"}, suggesting it might be a linkage mutation with G476S. Similarly, a combined mutation at codons 103 and 157 in FgCYP51 was observed in *F. graminearum* metconazole-resistant mutants ([@B11]).

In conclusion, baseline sensitivity using 110 *B. cinerea* isolates collected from nine provinces in China was established in this present study. As pyrisoxazole showed a high intrinsic activity on *B. cinerea* and no cross-resistance was found between pyrisoxazole and non-DMI fungicides, it indicated that pyrisoxazole can be used for better management of gray mold. Molecular docking models were used to predict how the mutations in the CYP51 binding pocket alter the binding of DMIs, suggesting that the G476S and M231T mutations combined with induced expression of the target gene appeared to mediate pyrisoxazole resistance of *B cinerea*. These results will be important for the control of the high-risk pathogen *B. cinerea* and may help in the development of more effective fungicides for disease management.
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